美国最高法院驳回普渡制药破产协议，萨克勒家族对阿片类药物危机负有责任。 US Supreme Court rejects Purdue Pharma bankruptcy deal, preserving Sackler family's liability for opioid crisis.

美国最高法院驳回了奥施康定生产商普渡制药的破产协议，该协议将使萨克勒家族免于因阿片类药物危机而引发的民事诉讼。 The US Supreme Court has rejected a bankruptcy deal for Purdue Pharma, the maker of OxyContin, that would have shielded the Sackler family from civil lawsuits over the opioid crisis. 法院以 5 比 4 的投票结果阻止了一项协议，该协议原本将为疫情受害者提供高达 60 亿美元的赔偿，同时使萨克勒家族免受未来与阿片类药物相关的诉讼。 The court's 5-4 decision blocks an agreement that would have provided up to $6 billion for victims of the epidemic while giving the Sackler family immunity from future opioid-related litigation. 该裁决是在拜登政府提出反对之后做出的，拜登政府认为该和解协议滥用了破产保护机制。 The ruling follows objections from the Biden administration, which argued that the settlement was an abuse of bankruptcy protections.